1.29BMarket Cap
LossP/E TTM
Integra Lifesciences Holdings Corp
Key Figures
17.150Open
17.590High
935.09KVolume
LossP/E TTM
6.35P/E Dynamic
--Dividend TTM
1.20%Turnover Ratio
17.120Prev. Close
16.240Low
11.95MTurnover
LossP/E Static
1.24P/B
0.00%Div Yield TTM
-13.00%ROA
16.62052wk High
0.63Volume Ratio
-6.94MNet Profit
77.89MShares
-6.4654EPS TTM
1.23Beta
-38.64%ROE
8.70052wk Low
7.89%Amplitude
54.90%Gross Margin
1.29BMarket Cap
-1.70Reward/Risk
3.43%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Integra Lifesciences Holdings Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 65 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 20.00.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Integra Lifesciences Holdings Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Integra Lifesciences Holdings Corp Highlights
StrengthsRisks
Integra Lifesciences Holdings Corp News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Integra Lifesciences Holdings Corp
IART
12
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Integra Lifesciences Holdings Corp Info
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
Ticker SymbolIART
CompanyIntegra Lifesciences Holdings Corp
CEOPoul (Mojdeh)
Websitehttps://www.integralife.com/
Shareholders
FAQs
What is the current price of Integra Lifesciences Holdings Corp (IART)?
The current price of Integra Lifesciences Holdings Corp (IART) is 16.65.
What is the symbol of Integra Lifesciences Holdings Corp?
The ticker symbol of Integra Lifesciences Holdings Corp is IART.
What is the 52-week high of Integra Lifesciences Holdings Corp?
The 52-week high of Integra Lifesciences Holdings Corp is 16.62.
What is the 52-week low of Integra Lifesciences Holdings Corp?
The 52-week low of Integra Lifesciences Holdings Corp is 8.70.
What is the market capitalization of Integra Lifesciences Holdings Corp?
The market capitalization of Integra Lifesciences Holdings Corp is 1.29B.
Is Integra Lifesciences Holdings Corp (IART) currently rated as Buy, Hold, or Sell?
According to analysts, Integra Lifesciences Holdings Corp (IART) has an overall rating of signal_hold, with a price target of 20.00.
What is the Earnings Per Share (EPS TTM) of Integra Lifesciences Holdings Corp (IART)?
The Earnings Per Share (EPS TTM) of Integra Lifesciences Holdings Corp (IART) is -6.74.
